유럽의 비침습적 산전 검사(NIPT) 시장 규모는 2023년 8억 5,920만 달러에 달했습니다. 이 시장은 2023-2033년 예측 기간 동안 14.16%의 CAGR로 성장하여 2033년에는 32억 3,060만 달러에 달할 것으로 예상됩니다. 유럽 NIPT 시장은 주로 유리한 가이드라인의 도입, 선별 검사 절차의 상환 정책 통합, 지속적인 기술 발전, 지역 내 상업적 기회 확대, 비침습적 검사법에 대한 선호도 증가에 힘입어 성장하고 있습니다.
| 주요 시장 통계 | |
|---|---|
| 예측 기간 | 2023-2033년 |
| 2023년 평가 | 8억 5,920만 달러 |
| 2033년 전망 | 32억 3,060만 달러 |
| CAGR | 14.16% |
유럽의 비침습적 산전 검사(NIPT) 시장은 최근 몇 년 동안 유전체 기술의 발전과 보다 안전하고 정확한 산전 검사 기술에 대한 수요 증가로 인해 크게 성장하고 있습니다. NIPT로 알려진 획기적인 방법은 산모의 혈류 내 무세포 태아 DNA를 분석하여 파타우 증후군, 에드워즈 증후군, 다운증후군과 같은 염색체 이상을 검사하는 방법입니다. NIPT는 비침습적이기 때문에 양수 천자와 같은 기존 진단 기술에 수반되는 위험이 없어 임산부와 의료진이 선호하고 있습니다.
우호적인 규제 프레임워크, 환자 및 의료 전문가들의 지식 증가, 공공 및 민간 의료 시스템에 NIPT의 통합은 모두 시장 성장에 기여하고 있으며, NIPT의 인기는 많은 유럽 국가들, 특히 산전 의료 인프라가 잘 구축된 지역에서의 상환 규정으로 인해 더욱 가속화되고 있습니다. 가속화되고 있습니다.
시장의 주요 참여자들은 NIPT 서비스의 경제성, 접근성, 정확성을 향상시키는 기술 발전에 초점을 맞추고 있습니다. 또한, 임신 후기의 추세와 산모의 고령화로 인해 신뢰할 수 있는 산전 검사 방법에 대한 필요성이 증가하고 있습니다. 그 결과, 유럽 NIPT 시장은 꾸준히 성장하여 지역 내 산모와 태아의 건강관리 성과를 개선하고 정보에 입각한 의사결정을 촉진하는 데 기여할 것으로 예상됩니다.
이 보고서는 유럽의 비침습적 산전 검사(NIPT) 시장에 대해 조사했으며, 시장 개요와 함께 방법별, 플랫폼별, 최종사용자별, 용도별, 국가별 동향, 시장 진입 기업 프로파일 등을 제공합니다.
Introduction to Europe Non-Invasive Prenatal Testing (NIPT) Market
The Europe NIPT market was valued at $859.2 million in 2023 and is expected to reach $3,230.6 million by 2033, registering a CAGR of 14.16% during the forecast period 2023-2033. The European NIPT market is primarily driven by the implementation of favorable guidelines, the inclusion of screening procedures in reimbursement policies, ongoing advancements in technology, expanding commercial opportunities across the region, and the growing preference for non-invasive testing methods.
Market Introduction
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2033 |
| 2023 Evaluation | $859.2 Million |
| 2033 Forecast | $3,230.6 Million |
| CAGR | 14.16% |
The market for non-invasive prenatal testing (NIPT) in Europe has grown significantly in recent years due to the development of genomic technologies and the increased need for prenatal screening techniques that are safer and more accurate. The ground-breaking method known as NIPT looks for chromosomal abnormalities such Patau syndrome, Edwards syndrome, and Down syndrome by analyzing cell-free fetal DNA in the mother's bloodstream. It is a preferred choice for pregnant parents and medical professionals because of its non-invasive nature, which removes the hazards connected to conventional diagnostic techniques like amniocentesis.
Favorable regulatory frameworks, growing patient and healthcare professional knowledge, and the incorporation of NIPT into both public and private healthcare systems all contribute to the market's growth. Its popularity has been further accelerated by reimbursement regulations in a number of European nations, especially in areas with established prenatal care infrastructure.
The market's major players are concentrating on technology advancements to improve the NIPT services' affordability, accessibility, and accuracy. Furthermore, the necessity for trustworthy prenatal screening methods has increased due to the tendency of late pregnancies and the aging of mothers. Consequently, the NIPT market in Europe is expected to increase steadily, contributing to better maternal and fetal healthcare outcomes throughout the area and facilitating informed decision-making.
Market Segmentation:
Segmentation 1: by Application
Segmentation 2: by End User
Segmentation 3: by Platform
Segmentation 4: by Method
Segmentation 5: by Country
How can this report add value to an organization?
Workflow/Innovation Strategy: The Europe NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others.
Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume.
Competitive Strategy: Key players in the Europe NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some prominent names established in this market are:
Scope and Definition